These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21592480)

  • 1. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
    Yunoki K; Nakamura K; Miyoshi T; Enko K; Kohno K; Morita H; Kusano KF; Ito H
    Atherosclerosis; 2011 Aug; 217(2):486-91. PubMed ID: 21592480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals - a randomized cross-over trial.
    Miyoshi T; Noda Y; Ohno Y; Sugiyama H; Oe H; Nakamura K; Kohno K; Ito H
    Biomed Pharmacother; 2014 Oct; 68(8):1071-7. PubMed ID: 25458786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.
    Westphal S; Abletshauser C; Luley C
    Coron Artery Dis; 2009 Jan; 20(1):81-5. PubMed ID: 19060628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease.
    Yunoki K; Nakamura K; Miyoshi T; Enko K; Kubo M; Murakami M; Hata Y; Kohno K; Morita H; Kusano KF; Ito H
    Am J Cardiol; 2011 Aug; 108(3):333-9. PubMed ID: 21545981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report.
    Noda Y; Miyoshi T; Oe H; Ohno Y; Nakamura K; Toh N; Kohno K; Morita H; Kusano K; Ito H
    Cardiovasc Diabetol; 2013 Jan; 12():8. PubMed ID: 23298374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
    Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
    Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
    Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
    Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.
    Westerink J; Deanfield JE; Imholz BP; Spiering W; Basart DC; Coll B; Kastelein JJ; Visseren FL
    Atherosclerosis; 2013 Mar; 227(1):118-24. PubMed ID: 23261174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.
    Ohno Y; Miyoshi T; Noda Y; Oe H; Toh N; Nakamura K; Kohno K; Morita H; Ito H
    Cardiovasc Diabetol; 2014 Apr; 13():71. PubMed ID: 24708775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease.
    Nakamura A; Sato K; Kanazawa M; Kondo M; Endo H; Takahashi T; Nozaki E
    Heart Vessels; 2019 Jun; 34(6):916-925. PubMed ID: 30519809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
    Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
    Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles.
    Wilmink HW; Twickler MB; Banga JD; Dallinga-Thie GM; Eeltink H; Erkelens DW; Rabelink TJ; Stroes ES
    Cardiovasc Res; 2001 Jun; 50(3):577-82. PubMed ID: 11376633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia.
    Lee SH; Park S; Kang SM; Jang Y; Chung N; Choi D
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):65-71. PubMed ID: 21386036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postprandial lipemia induces endothelial dysfunction and higher insulin resistance in healthy subjects].
    Ramírez-Vélez R
    Endocrinol Nutr; 2011 Dec; 58(10):529-35. PubMed ID: 22078763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artichoke juice improves endothelial function in hyperlipemia.
    Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
    Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ezetimibe on lipid and glucose metabolism after a fat and glucose load.
    Hiramitsu S; Miyagishima K; Ishii J; Matsui S; Naruse H; Shiino K; Kitagawa F; Ozaki Y
    J Cardiol; 2012 Nov; 60(5):395-400. PubMed ID: 22890076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I; Tarján J; Császár A
    Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.